Advances in immunotherapy for lymphoma

Martin Hutchings, MD, PhD, Copenhagen University Hospital, Copenhagen, Denmark, provides an overview of current developments in the field of immunotherapy in lymphoma. A lot of progress has been made in monoclonal antibodies, bispecific antibodies, as well as chimeric antigen receptor (CAR) T-cell therapies. Dr Hutchings additionally comments on looking forward to the next generation of immunotherapies, such as anti-CD20 IgM antibodies. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.